Espoo
Finland
27
2022-05-26
26
2024-03-26
These are the the leading inventors for applications assigned to ZORA BIOSCIENCES OY:
ZORA BIOSCIENCES OY based in Espoo, FI has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Ceramides and their use in diagnosing CVD
#2 | 2022-01-06 ✅ Patent 12,399,188 granted on 2025-08-26BIOMARKERS FOR CARDIOVASCULAR EVENTS
#3 | 2021-08-05 ✅ Patent 12,270,816 granted on 2025-04-08Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#4 | 2021-01-07 ✅ Patent 12,025,623 granted on 2024-07-02Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#5 | 2020-11-05 ✅ Patent 12,313,634 granted on 2025-05-27Methods for prediction and early detection of diabetes
#6 | 2020-01-02 ✅ Patent 10,955,427 granted on 2021-03-23Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#7 | 2019-04-18 ✅ Patent 11,474,116 granted on 2022-10-18Ceramides and their use in diagnosing CVD
#8 | 2018-11-08 ✅ Patent 10,551,394 granted on 2020-02-04Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#9 | 2018-03-08 ✅ Patent 10,261,101 granted on 2019-04-16Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#10 | 2017-10-05 ✅ Patent 10,534,001 granted on 2020-01-14Methods for detecting ovarian cancer
#11 | 2017-06-08 ✅ Patent 10,184,932 granted on 2019-01-22Use of ceramides and LPLs in diagnosing CVD
#12 | 2016-12-15 ✅ Patent 9,857,386 granted on 2018-01-02Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#13 | 2016-11-03 ✅ Patent 9,863,965 granted on 2018-01-09Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
#14 | 2016-09-15 ✅ Patent 10,197,582 granted on 2019-02-05Ceramides and their use in diagnosing CVD
#15 | 2016-01-28 ✅ Patent 9,841,431 granted on 2017-12-12Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#16 | 2015-12-17 ✅ Patent 9,347,960 granted on 2016-05-24Ceramides and their use in diagnosing CVD
#17 | 2015-09-17 ✅ Patent 9,459,265 granted on 2016-10-04Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
#18 | 2015-09-17 ✅ Patent 9,423,406 granted on 2016-08-23Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
#19 | 2015-09-03 ✅ Patent 9,459,264 granted on 2016-10-04Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#20 | 2014-10-02 ✅ Patent 9,052,328 granted on 2015-06-09Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
#21 | 2014-10-02 ✅ Patent 9,052,327 granted on 2015-06-09Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
#22 | 2014-01-30 ✅ Patent 9,664,698 granted on 2017-05-30Biomarkers for sensitive detection of statin-induced muscle toxicity
#23 | 2013-08-22 ✅ Patent 9,201,080 granted on 2015-12-01Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#24 | 2013-02-21 ✅ Patent 9,046,538 granted on 2015-06-02Lipidomic biomarkers for atherosclerosis and cardiovascular disease
#25 | 2012-10-11 ✅ Patent 9,541,565 granted on 2017-01-10Biomarkers for sensitive detection of statin-induced muscle toxicity
#26 | 2009-12-24BIOFLUID METABOLITE PROFILING AS A TOOL FOR EARLY PREDICTION OF AUTOIMMUNITY AND TYPE 1 DIABETES RISK
#27 | 2008-01-03 ✅ Patent 7,611,902 granted on 2009-11-03Diagnostic method for myopathy
Also check out ZORA BIOSCIENCES OY's (Espoo, Finland) applicant profile with 24 patent applications submitted.
10362 ⎘